Daphnetin Ameliorates Neuropathic Pain via Regulation of Microglial Responses and Glycerophospholipid Metabolism in the Spinal Cord

Wulin Liang,Tianrui Zhang,Mingqian Zhang,Jiahui Gao,Rikang Huang,Xiyan Huang,Jianhua Chen,Lu Cheng,Liyuan Zhang,Zhishan Huang,Qiling Tan,Zhanhong Jia,Shuofeng Zhang

DOI: https://doi.org/10.3390/ph17060789

IF: 4.6

2024-06-17

Pharmaceuticals

Abstract:Neuropathic pain (NP) is a common type of chronic pain caused by a lesion or disease of the somatosensory nervous system. This condition imposes a considerable economic burden on society and patients. Daphnetin (DAP) is a natural product isolated from a Chinese medicinal herb with various pharmacological activities, such as anti-inflammatory and analgesic properties. However, the underlying mechanisms of these effects are not fully understood. In the present study, we aimed to investigate DAP's anti-inflammatory and analgesic effects and explore the underlying mechanisms of action. The NP model was established as chronic constrictive injury (CCI) of the sciatic nerve, and pain sensitivity was evaluated by measuring the mechanical withdrawal threshold (MWT) and thermal withdrawal threshold (TWT). The activation of microglia in the spinal dorsal horn was measured via immunofluorescence staining. Protein levels were measured using a western blot assay. Using a mass-spectrometry proteomics platform and an LC-MS/MS-based metabolomics platform, proteins and metabolites in spinal cord tissues were extracted and analyzed. DAP treatment ameliorated the MWT and TWT in CCI rats. The expression of IL-1β, IL-6, and TNF-α was inhibited by DAP treatment in the spinal cords of CCI rats. Moreover, the activation of microglia was suppressed after DAP treatment. The elevation in the levels of P2X4, IRF8, IRF5, BDNF, and p-P38/P38 in the spinal cord caused by CCI was inhibited by DAP. Proteomics and metabolomics results indicated that DAP ameliorated the imbalance of glycerophospholipid metabolism in the spinal cords of CCI rats. DAP can potentially ameliorate NP by regulating microglial responses and glycerophospholipid metabolism in the CCI model. This study provides a pharmacological justification for using DAP in the management of NP.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether Daphnetin (DAP) can improve neuropathic pain (NP) by regulating microglial cell responses and glycerophospholipid metabolism in the spinal cord. Specifically, the research aims to: 1. **Verify the anti - inflammatory and analgesic effects of DAP**: By establishing a neuropathic pain model of chronic constrictive injury (CCI), evaluate the effects of DAP on mechanical withdrawal threshold (MWT) and thermal withdrawal threshold (TWT). 2. **Explore the mechanism of action of DAP**: - **Inhibition of microglial cell activation**: Detect the expression of Iba - 1 in the spinal dorsal horn by immunofluorescence staining to evaluate the inhibitory effect of DAP on microglial cell activation. - **Inhibition of inflammatory factor expression**: Detect the protein levels of TNF - α, IL - 1β and IL - 6 in the spinal cord by Western Blot to evaluate the inhibitory effect of DAP on inflammatory factor expression. - **Regulation of P2X4 receptor**: Detect the expression of P2X4 receptor in spinal microglial cells by Western Blot and immunofluorescence double - staining to evaluate the regulatory effect of DAP on P2X4 receptor. - **Inhibition of MAPK signaling pathway**: Detect the protein levels of P38, JNK and ERK1/2 and their phosphorylated forms by Western Blot to evaluate the inhibitory effect of DAP on MAPK signaling pathway. 3. **Proteomics and metabolomics analysis**: - **Proteomics**: Use TMT quantitative proteomics technology to screen out differentially expressed proteins between the CCI group and the DAP group, and perform GO annotation and KEGG pathway enrichment analysis to reveal the effect of DAP on spinal cord protein expression. - **Metabolomics**: Conduct non - targeted metabolomics research, identify differentially expressed metabolites between the CCI group and the DAP group, and evaluate the effect of DAP on spinal cord metabolic function through multi - dimensional statistical analysis (such as OPLS - DA). Through the above experimental design, researchers hope to fully understand the mechanism of action of DAP in improving neuropathic pain and provide a scientific basis for its clinical application.

Daphnetin Ameliorates Neuropathic Pain via Regulation of Microglial Responses and Glycerophospholipid Metabolism in the Spinal Cord

Daphnetin Improves Neuropathic Pain by Inhibiting the Expression of Chemokines and Inflammatory Factors in the Spinal Cord and Interfering with Glial Cell Polarization

Itaconate as a Promising Therapy for Neuropathic Pain and Inflammatory Pain

Duhuo Jisheng decoction alleviates neuroinflammation and neuropathic pain by suppressing microglial M1 polarization: a network pharmacology research

[Tetrahydropalmatine alleviated diabetic neuropathic pain by inhibiting activation of microglia via p38 MAPK signaling pathway]

Daphnetin inhibits spinal glial activation via Nrf2/HO-1/NF-κB signaling pathway and attenuates CFA-induced inflammatory pain

Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models

Electroacupuncture alleviates neuropathic pain caused by spared nerve injury by promoting AMPK/mTOR-mediated autophagy in dorsal root ganglion macrophage

Network pharmacology-based prediction of active ingredient and Mechanisms of Astragalus membranaceus and Panax notoginseng coupled-herbs against Diabetic neuropathic pain

Delayed Inhibition of ERK and P38 Attenuates Neuropathic Pain Without Affecting Motor Function Recovery after Peripheral Nerve Injury.

Unveiling Adcyap1 As a Protective Factor Linking Pain and Nerve Regeneration Through Single-Cell RNA Sequencing of Rat Dorsal Root Ganglion Neurons.

Down-regulation of microRNA-382-5p reduces neuropathic pain by targeting regulation of dual specificity phosphatase-1

Catestatin Enhances Neuropathic Pain Mediated by P2X4 Receptor of Dorsal Root Ganglia in a Rat Model of Chronic Constriction Injury

Suppression of peripheral NGF attenuates neuropathic pain induced by chronic constriction injury through the TAK1-MAPK/NF-κB signaling pathways

Electroacupuncture Alleviates Diabetic Neuropathic Pain and Downregulates p-PKC and TRPV1 in Dorsal Root Ganglions and Spinal Cord Dorsal Horn

Activation of G protein-coupled receptor 39 alleviates neuropathic pain and chronic inflammation

Anti-Allodynic Effects of Polydeoxyribonucleotide in an Animal Model of Neuropathic Pain and Complex Regional Pain Syndrome

ANA-12 Promotes Astrocyte Autophagy in Neuropathic Pain by Modulating TRKB/mTOR/c-JUN Axis

Frankincense-Myrrh treatment alleviates neuropathic pain via the inhibition of neuroglia activation mediated by the TLR4/MyD88 pathway and TRPV1 signaling

Tetrandrine attenuates SNI-induced mechanical allodynia by inhibiting spinal CKLF1

Systematic Administration of B Vitamins Alleviates Diabetic Pain and Inhibits Associated Expression of P2X3 and TRPV1 in Dorsal Root Ganglion Neurons and Proinflammatory Cytokines in Spinal Cord in Rats